Xact Kapitalforvaltning’s Amneal Pharmaceuticals AMRX Stock Holding History

Xact Kapitalforvaltning’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$66K	Hold	18,874	–	–	﹤0.01%	1300
2019 Q4	$91K	Hold	18,874	–	–	﹤0.01%	1404
2019 Q3	$55K	Hold	18,874	–	–	﹤0.01%	1427
2019 Q2	$135K	Hold	18,874	–	–	﹤0.01%	1421
2019 Q1	$267K	Hold	18,874	–	–	0.01%	1282
2018 Q4	$255K	Sell	18,874 -500	-3%	-$9.01K	0.01%	1321
2018 Q3	$430K	Buy	19,374 +7,000	+57%	+$147K	0.01%	1087
2018 Q2	$203K	Buy	+12,374	New	+$217K	﹤0.01%	1546

Other funds holding AMRX

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Xact Kapitalforvaltning's AMRX Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Amneal Pharmaceuticals (AMRX) position steady in Q1 2020 at 18,874 shares worth $66K. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

Xact Kapitalforvaltning first reported a position in AMRX in Q2 2018 and has held it in 8 quarters since. The position peaked at $430K in Q3 2018. 127 funds tracked by Wall St. Rank hold AMRX as of Q1 2020.

Xact Kapitalforvaltning held 18,874 shares of Amneal Pharmaceuticals worth $66K as of Q1 2020.
Xact Kapitalforvaltning left its Amneal Pharmaceuticals share count unchanged in Q1 2020.
Amneal Pharmaceuticals made up ﹤0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1300 holding.
Xact Kapitalforvaltning first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 8 quarters since.
Xact Kapitalforvaltning's Amneal Pharmaceuticals position peaked at $430K in Q3 2018.
127 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.